"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"

计划入组 25 人 · 首次发布于 2022 年 6 月 8 日

Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression

计划入组 296 人 · 首次发布于 2011 年 8 月 1 日

The BRIDGE Study - Bronchiectasis Research Involving Databases, Genomics and Endotyping

计划入组 1,000 人 · 首次发布于 2019 年 1 月 2 日

MBRC-101

MBRC-301

MBRC-201

Embera Neurotherapeutics, Inc.

United States

Decramer Marc

Belgium

Kiviniemi, Marc

United States

EMBARC and Insmed Announce Landmark 3,000-Patient Study to Evaluate Whether Brensocatib Can Modify the Course of Bronchiectasis

Israeli Healthtech Innovation Drives Global Healthcare Solutions

Biomarker-Guided Antidepressant Selection Boosts Response Rates by Nearly 67% in Precision Psychiatry Trial